<!DOCTYPE html>
<html>
  <head>
    <title>Safe Prescription, without Error, of CMV-negative and Irradiated blood through App-based Learning (SPECIAL)</title>
  	<meta name="viewport" content="width=device-width, initial-scale=1">
    <link rel="stylesheet" href="http://code.jquery.com/mobile/1.4.2/jquery.mobile-1.4.2.min.css" />
    <script src="http://code.jquery.com/jquery-1.9.1.min.js"></script>
    <script src="http://code.jquery.com/mobile/1.4.2/jquery.mobile-1.4.2.min.js"></script>
    <style>
      .special {color: #C00; text-decoration: underline; font-weight: bold;}
      .noline {text-decoration: none;font-style: italic;}
    </style>
    
        
    <!-- Google Analytics -->
    
    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','//www.google-analytics.com/analytics.js','ga');
      var sessionID = "0";
      ga('create', 'UA-44958852-1', 'optimalblooduse.eu');
      ga(function(tracker) {
        sessionID = tracker.get('clientId');
        ga('set', 'dimension1', sessionID);
        $("#buttons").append('<a style="background:#5d5;" href="randomise.php?s=' + sessionID + '&b=g" data-role="button">Greater Glasgow and Clyde</a>').append('<a style="background:#5d5;" href="randomise.php?s=' + sessionID + '&b=o" data-role="button">Other Scottish Health Board</a>').trigger("create");
        
        
      });
      ga('send', 'pageview');
    
    </script>
    
    <!-- End Google Analytics -->

  </head>
  
  <body>
    
    <div data-role="page">
    
    	<div data-role="main" class="ui-content">
      
        <h1>Welcome to <span class="special noline">SPECIAL</span></h1>
        
        <p style="background:#AFA; text-align: center; margin: 1em; border: 0px dashed; padding: 0.5em; border-radius: 3px;"><strong>The trial is currently actively recruiting.</strong></p>
        
        <p style="margin: 1em; border: 1px dashed; padding: 0.5em; border-radius: 3px;"><span class="special">S</span>topping and <span class="special">P</span>reventing <span class="special">E</span>rrors in <span class="special">C</span>MV-negative and <span class="special">I</span>rradiated blood transfusions through <span class="special">A</span>pp-based <span class="special">L</span>earning.</p>

        <p>This is the home page for the Scottish <span class="special noline">SPECIAL</span> online clinical trial. Explore the sections below to find out more.</p>
        
        <div data-role="collapsibleset">
          
          <div data-role="collapsible">
          
              
            <h2>Background</h2>
            
            <p>Although blood transfusion in the UK is safe, it is a complex process and mistakes can occur at various stages.</p>
            
            <p>Some patients have an elevated risk of developing transfusion-associated Graft versus Host Disease (TA-GvHD). This is a rare but usually lethal condition that can be avoided by irradiating cellular blood components.</>
            
            <p>Transfusion can also transmit cytomegalovirus (CMV) infection, which can lead to serious conditions in vulnerable patients. CMV-negative blood components should therefore be provided to these patients.</p>
            
            <p>Every year approximately one hundred mistakes related to failures to provide irradiated and CMV-negative blood components to patients according to guidelines are reported to the UK haemovigilance scheme SHOT.</p>
            
            <p>This trial will investigate the effectiveness of an app-based learning intervention in enhancing prescribers' knowledge and raising awareness of the underlying causes.</p>
            
          </div>
          
          <div data-role="collapsible">
          
            <h2>Objectives</h2>
        
            <ol>
              <li>What is the current state of knowledge of the indications for irradiated and CMV-negative blood components among doctors and nurses who prescribe blood?<br/><br/></li>

              <li>How do access to a mobile app influence prescription of irradiated and CMV-negative blood in simulated patient scenarios?<br/><br/></li>

              <li>How do participants rate the mobile app and existing local or UK guidelines?</li>
            
            </ol>
            
          </div>
          
          <div data-role="collapsible">
            <h2>Methodology</h2>
            <p>Randomised controlled trial comparing participants' prescribing behaviour under two conditions:</p>
            <ol>
              <li>Current practice based on access to local and national guidelines (control group).<br/><br/></li>
              <li>Novel intervention based on access to an app with learning material (treatment group)</li>
            </ol>
            <p>Participants are randomly allocated one of the trial arms. To provide a baseline and capture group variance, participants are asked to answer a pre- and post-test with ten questions based on simulated patient scenarios.</p>
            <p>Please see protocol for a schematic.</p>
            </div>
          
          <div data-role="collapsible">
            <h2>Protocol</h2>
            <img src="trialdesign.png" style="max-width:1000px; width: 100%"/>
          </div>
          
          
          <div data-role="collapsible">
            <h2>Investigators</h2>
            
            <p><strong>Karl Monsen</strong><br/>
            Karl is a PhD candidate at The University of Edinburgh, investigating the design, use and evaluation of apps in medicine. He is the developer of an app aiming to improve the prescription of irradiated and CMV-negative blood components.<br/>
            <a href="mailto:kd.monsen@sms.ed.ac.uk" data-role="button">Email Karl</a>
            
            <p><strong>Dr. Brian McClelland</strong><br/>
            Dr. McClelland is medical adviser to the project. He is the editor of the fourth edition of the Handbook of Transfusion Medicine and a widely published expert in blood transfusion.</p>  

            <p>This trial is supported by the BBT team at the SNBTS.</p>

          </div>
          
        </div>
          
      
                
        <h1>Participate</h1>
        

        <p>If you match the inclusion criteria, please read the terms of participation and join the trial.</p>
        
        <div data-role="collapsibleset">
          <div data-role="collapsible">
            <h2>Inclusion criteria</h2>
            
            <p>Inclusion criteria:</p>
            <ul>
              <li>Nurses and doctors authorised to prescribe blood transfusion and who are working in Scotland.</li>
            </ul>
            <p>Exclusion criteria:</p>
            <ul>
              <li>Nurses who do not have blood transfusion authoriser status.</li>
              <li>Nurses and doctors working outside of Scotland.</li>
            </ul>
            
          </div>
          
          <div data-role="collapsible">
            <h2>Terms of participation</h2>
            <p>Please read this section carefully.</p>
            
            <p>If you choose to participate, you will be asked to:</p>
            
            <ol>
              <li>Answer ten questions about irradiated and CMV-negative blood to the best of your knowledge without consulting any external source.<br/><br/></li>
              <li>Explore local or national guidelines, or a mobile app.<br/><br/></li>
              <li>Amend your answers based on any new information you may have gained and evaluate the quality of the resource you accessed.<br/><br/></li>
              <li>Provide some background information on your experience, specialty and willingness to participate in a brief follow-up survey.</li>
            </ol>
            
            <p>It should take approximately 15 minutes to complete.</p>
            
            <p>Use of your data</p>
            
            <ol>
              <li>Any data you provide will be treated confidentially.</li>
              <li>Your answers will be made anonymous in any publications.</li>
              <li>You may withdraw from the research at any time for any reason.</li>
              <li>Data will not be shared outwith the research team and held securely.</li>
              <li>Personally identifiable information will not be collected unless you choose to disclose a contact email should you wish to also participate in the follow up survey.</li>
            </ol>
            <p>Please contact us if you have any questions about any of the above. See contact details above.</p>
            
          </div>

        <p>By proceeding you are indicating your informed consent to participate in the research.</p>
        
        <p>Please select your Health Board to begin:</p>
        
        <div id="buttons">
        </div>

        <a  style="background:#faa;"href="javascript: alert('Sorry, you do not match the inclusion criteria.\nWe are recruiting Scottish nurses and doctors only.')" data-role="button">I'm outside Scotland</a>
      </div>
    
    </div>
  
  </body>
</html>